Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Anita Pusztai"'
Autor:
Diána Simon, Dorottya Kacsándi, Anita Pusztai, Boglárka Soós, Edit Végh, György Kerekes, Monika Bodoki, Szilvia Szamosi, Gabriella Szűcs, Zoltán Prohászka, Péter Németh, Tímea Berki, Zoltán Szekanecz
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 6, p 3429 (2024)
Cardiovascular (CV) morbidity and mortality have been associated with rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Natural autoantibodies (nAAb) are involved in innate immunity, as well as autoimmunity, inflammation, and atherosclerosis
Externí odkaz:
https://doaj.org/article/71f2a4f53dee47f8860debc5ee7c805e
Autor:
Dorottya Kacsándi, Miklós Fagyas, Ágnes Horváth, Edit Végh, Anita Pusztai, Monika Czókolyová, Boglárka Soós, Attila Ádám Szabó, Attila Hamar, Zsófia Pethő, Nóra Bodnár, György Kerekes, Katalin Hodosi, Szilvia Szamosi, Gabriella Szűcs, Zoltán Papp, Zoltán Szekanecz
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionThe Renin-Angiotensin-Aldosterone system (RAAS) has been implicated in the regulation of the cardiovascular system and linked to rheumatoid arthritis (RA). Little information has become available on the effects of Janus kinase (JAK) inhib
Externí odkaz:
https://doaj.org/article/f41fec7a849149948aedbbc135bef895
Autor:
Balázs Juhász, Katalin Gulyás, Ágnes Horváth, Edit Végh, Anita Pusztai, Ágnes Szentpétery, Zsófia Pethő, Nóra Bodnár, Attila Hamar, Levente Bodoki, Harjit Pal Bhattoa, Éva Szekanecz, Katalin Hodosi, Andrea Domján, Szilvia Szamosi, Csaba Horváth, Sándor Szántó, Gabriella Szűcs, Hennie G. Raterman, Willem F. Lems, Oliver FitzGerald, Zoltán Szekanecz
Publikováno v:
BMC Musculoskeletal Disorders, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Introduction Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are associated with osteoporosis. There have not been many peripheral quantitative computed tomography (QCT) studies in patients receiving biologics. We assessed volumetr
Externí odkaz:
https://doaj.org/article/854910d3b56d4171a2efafc3c61464fd
Autor:
Anita Pusztai, Attila Hamar, Monika Czókolyová, Katalin Gulyás, Ágnes Horváth, Edit Végh, Zsófia Pethő, Szilvia Szamosi, Emese Balogh, Nóra Bodnár, Levente Bodoki, Ágnes Szentpétery, Harjit Pal Bhattoa, György Kerekes, Balázs Juhász, Éva Szekanecz, Katalin Hodosi, Andrea Domján, Sándor Szántó, Hennie G. Raterman, Willem F. Lems, Zoltán Szekanecz, Gabriella Szűcs
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Cardiovascular (CV) disease and osteoporosis (OP) have been associated with rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Bone and vascular biomarkers and parameters along with the effect of 1-year anti-TNF therapy on these mark
Externí odkaz:
https://doaj.org/article/81ecefe24d80492490c1152dcc6c8038
Autor:
Boglárka Soós, Attila Hamar, Anita Pusztai, Monika Czókolyová, Edit Végh, Szilvia Szamosi, Zsófia Pethő, Katalin Gulyás, György Kerekes, Sándor Szántó, Gabriella Szűcs, Uwe Christians, Jelena Klawitter, Tamás Seres, Zoltán Szekanecz
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
IntroductionRheumatoid arthritis (RA) has been associated with changes in lipid, arginine and NO metabolism with increased cardiovascular (CV) risk. The aim of this study is to evaluate the effect of tofacitinib, a Janus kinase (JAK) inhibitor, on ar
Externí odkaz:
https://doaj.org/article/a6061826902b48d89056abe612f96e15
Autor:
Boglárka Soós, Miklós Fagyas, Ágnes Horváth, Edit Végh, Anita Pusztai, Monika Czókolyová, Alexandra Csongrádi, Attila Hamar, Zsófia Pethő, Nóra Bodnár, György Kerekes, Katalin Hodosi, Éva Szekanecz, Szilvia Szamosi, Sándor Szántó, Gabriella Szűcs, Zoltán Papp, Zoltán Szekanecz
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
IntroductionAngiotensin-converting enzyme (ACE) and ACE2 have been implicated in the regulation of vascular physiology. Elevated synovial and decreased or normal ACE or ACE2 levels have been found in rheumatoid arthritis (RA). Very little is known ab
Externí odkaz:
https://doaj.org/article/9be3049328d844bfb17fcc4b90d78fb4
Autor:
Zoltan Szekanecz, Gabriella Szücs, Boglarka Soos, Attila Hamar, Szilvia Szamosi, Sándor Szántó, Edit Végh, Anita Pusztai, György Kerekes, Katalin Hodosi, Zsolt Hascsi, Monika Czókolyová, Zsófia Pethő, Katalin Gulyás, Éva Szekanecz, Tamás Seres
Publikováno v:
RMD Open, Vol 7, Iss 3 (2021)
Externí odkaz:
https://doaj.org/article/e3f6b6623c4749148a1889776b2c2f94
Autor:
Ágnes Horváth, Edit Végh, Anita Pusztai, Zsófia Pethő, Attila Hamar, Monika Czókolyová, Harjit Pal Bhattoa, Gábor Nagy, Balázs Juhász, Katalin Hodosi, Andrea Domján, Zoltán Szekanecz, Gabriella Szücs, Szilvia Szamosi
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-10 (2019)
Abstract Objective We wished to determine bone alterations in systemic sclerosis (SSc) patients by conventional densitometry (DXA), peripheral quantitative computed tomography (pQCT), and bone biomarkers. Methods We included 44 SSc patients and 33 ag
Externí odkaz:
https://doaj.org/article/73dc4cfb35db4d0abfd55541c1c27560
Autor:
Monika Czókolyová, Attila Hamar, Anita Pusztai, Gábor Tajti, Edit Végh, Zsófia Pethő, Nóra Bodnár, Ágnes Horváth, Boglárka Soós, Szilvia Szamosi, Anita Szentpéteri, Ildikó Seres, Mariann Harangi, György Paragh, György Kerekes, Levente Bodoki, Andrea Domján, Katalin Hodosi, Tamás Seres, György Panyi, Zoltán Szekanecz, Gabriella Szűcs
Publikováno v:
Biomolecules, Vol 12, Iss 10, p 1483 (2022)
Background: Cardiovascular (CV) morbidity, mortality and metabolic syndrome are associated with rheumatoid arthritis (RA). A recent trial has suggested increased risk of major CV events (MACE) upon the Janus kinase (JAK) inhibitor tofacitinib compare
Externí odkaz:
https://doaj.org/article/1bf883c526d04d30b1814f3d8a0c694f
Autor:
Szilárd Póliska, Timea Besenyei, Edit Végh, Attila Hamar, Anita Pusztai, Andrea Váncsa, Nóra Bodnár, Szilvia Szamosi, Mária Csumita, György Kerekes, Zoltán Szabó, Zoltán Nagy, Gabriella Szűcs, Sándor Szántó, Gábor Zahuczky, László Nagy, Zoltán Szekanecz
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-11 (2019)
Abstract Objectives Impaired vascular pathophysiology and increased cardiovascular (CV) mortality are associated with rheumatoid arthritis (RA). To date, no genomic analysis of RA- and RA treatment-related vascular pathophysiology has been published.
Externí odkaz:
https://doaj.org/article/269cc2dae60e4a5dbd34ea4501932adc